“The [ratings action reflects] our view of AHCN’s extremely solid enterprise profile, which includes a leading market position in the Chicagoland market and its national reputation in developing a strong clinically integrated physician network model, which has allowed it to successfully manage increasing value-based reimbursement,” said S&P analyst Suzie Desai.
The ratings agency also affirmed the ratings on AHCN’s following bonds:
- “AA+/A-1+” on its various series of variable rate demand bonds
- “A-1+” short-term rating on its series 2008C-3B bonds
The outlook is stable, reflecting S&P’s view of AHCN’s continued market leadership, extensive physician network and solid financial profile.
More articles on healthcare finance:
12 recent hospital outlook and credit rating actions
Moody’s affirms ‘Baa2’ rating on St. Anthony Regional Hospital’s bonds
Tenet, Baptist Health System in talks with BCBS of Texas for 10 months
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
